Biogen discusses its Alzheimer’s disease research activities at the Alzheimer’s Association International Conference (AAIC) 2026. Two Seeking Alpha items reference Biogen’s participation through a conference transcript and a related slideshow presentation. The materials indicate that Biogen uses the AAIC venue to update stakeholders on ongoing work related to Alzheimer’s, reflecting continued engagement with the scientific community around the conference’s research focus. While the provided source text does not include specific study results, metrics, or conclusions, it frames the content as a formal company presentation delivered at AAIC 2026, along with a transcript capturing remarks and a visual deck summarizing key points. Across both entries, the common element is Biogen’s presentation at AAIC 2026, distributed in two formats—verbatim transcript and slideshow—suggesting the company is communicating its latest perspectives on its Alzheimer’s portfolio during the conference. Readers seeking detailed findings are directed to the transcript and slideshow materials for the specific claims, data, and context presented by the company.